- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 565
Skoda skips from Workday to Morgan Stanley
Workday Ventures has lost its vice-president of investments, Brittany Skoda, less than two years after she joined the corporate venturing unit from Goldman Sachs.
Feb 18, 2020Carevive receives $15m in series C funding
Debiopharm Innovation Fund and Philips Health Technology Ventures both contributed to the latest round for the cancer care software producer.
Feb 18, 2020Summit 2020 covers AI, dealflow and more
The Global Corporate Venturing and Innovation Summit 2020 in Monterey, California, brought together more than 800 corporate venturing leaders from corporations representing about $10 trillion in annual revenues.
Feb 18, 2020Daily deal net: February 17, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 17, 2020Toast gets $400m meal
The Alphabet-backed restaurant management platform developer's series F round valued it at $4.9bn and it has now received more than $900m in funding altogether.
Feb 17, 2020CloudCath cleans up with series A funding
Stanford-StartX Fund contributed to a $12m round for catheter monitor developer CloudCath, whose clinical advisory chairman hails from Stanford University.
Feb 17, 2020BlockFi locks in $30m
The crypto finance product developer has now raised more than $110m altogether, with CMT Digital returning for its series B round.
Feb 17, 2020Datometry draws $17m in series B round
Dell Technologies Capital reinvested as part of a series B round for the virtualisation platform developer having backed its series A in 2017.
Feb 17, 2020Corporate venturing deal net: 10-14 February 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds
Feb 14, 2020Revolution hits public markets in $238m IPO
The precision cancer therapy developer, based on research from several universities, floated at the top of an upsized range and saw its price continue to rise post-IPO.
Feb 14, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


